Evaluation Of Certain Veterinary Drug Residues In Food 62nd Meeting, 2004 (Technical Report Series, 925)
Description:
This report presents the conclusions of a Joint FAO/WHO Expert Committee convened to evaluate the safety of residues of certain veterinary drugs in food and to recommend maximum levels for such residues in food. The first part considers conslusions on specific toxicological end-points lipid-soluble residues of veterinary drugs with MRLs in milk statistical methods for the estimation of MRLs and the Committee's review and comments on documents provided by Codex Committees. Summaries follow of the Committee's evaluations of toxicological and residue data on a variety of veterinary drugs: five antibacterial agents (cefuroxime chloramphenicol flumequine lincomycin pirlimycin) four insecticides (cyhalothrin cypermethrin and a-cypermethrin doramectin phoxim) and two production aids (melengestrol acetate ractopamine). The Committee's comments on chloramphenicol found at low levels in animal products are also summarized. Annexed to the report is a summary of the Committee's recommendations on these drugs including acceptable daily intakes and proposed maximum residue limits.
Best prices to buy, sell, or rent ISBN 9789241209250
Frequently Asked Questions about Evaluation Of Certain Veterinary Drug Residues In Food 62nd Meeting, 2004 (Technical Report Series, 925)
The price for the book starts from $11.75 on Amazon and is available from 2 sellers at the moment.
If you’re interested in selling back the Evaluation Of Certain Veterinary Drug Residues In Food 62nd Meeting, 2004 (Technical Report Series, 925) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Evaluation Of Certain Veterinary Drug Residues In Food 62nd Meeting, 2004 (Technical Report Series, 925) book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.